QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.061416v1 309/1/182    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Billman, G. E. Articles by Gögelein, H. Search for Related Content PubMed PubMed Citation Articles by Billman, G. E. Articles by Gögelein, H.

CARDIOVASCULAR

Effects of a Novel Cardioselective ATP-Sensitive Potassium Channel Antagonist, 1-[[5-[2-(5-Chloro-o-anisamido)ethyl]--methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, Sodium Salt (HMR 1402), on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia: In Vitro and in Vivo Studies

Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio (G.E.B., M.S.H.); and Aventis Pharma, Frankfurt, Germany (H.C.E., H.G.)

In the present study, a novel sulfonylthiourea, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]--methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), was investigated using in vitro and in vivo systems. HMR 1402 inhibited rilmakalim-induced currents in rat and guinea pig myocytes (IC₅₀ = 60 and 509 nM, respectively). Hypoxia-induced shortening of action potential duration at 90% repolarization was also significantly attenuated by HMR 1402 (68.1 ± 3.9% of control at 0.3 µM). In contrast, HMR 1402 had a smaller effect on pancreatic -cells (rat insuloma cells, RINm5F) hyperpolarized with 100 µM diazoxide (IC₅₀ = 3.9 µM, compared with glibenclamide IC₅₀ = 9 nM). In a similar manner, hypoxia induced increases in coronary flow in isolated guinea pig hearts were only slightly reduced by HMR 1402. These data strongly suggest that HMR 1402 has pharmacological selectivity for cardiac myocytes and, therefore, may protect against ischemically induced ventricular fibrillation (VF) without the untoward effects of nonselective compounds. To test this hypothesis, VF was induced in 8 dogs with healed myocardial infarctions by a 2-min coronary occlusion during the last minute of exercise. On a subsequent day, the exercise plus ischemia test was repeated after HMR 1402 (3.0 mg/kg i.v., n = 4, infusion 4 µg/kg/min for 1 h before exercise, n = 4). This drug significantly reduced the incidence of VF protecting seven of eight animals (p = 0.0007) without altering plasma insulin, blood glucose, or the increases in mean coronary blood flow induced by either exercise or 15-s coronary occlusions. Thus, the ATP-sensitive potassium channel antagonist HMR 1402 can prevent ischemically induced VF without altering coronary blood flow or blood glucose.

This article has been cited by other articles:

				A. Bauer, R. Becker, J. Dreyhaupt, F. Voss, P. Kraft, K. Kelemen, J. C. Senges-Becker, H. A. Katus, and W. Schoels Role of KATP channels in repetitive induction of ventricular fibrillation Europace, March 1, 2007; 9(3): 154 - 161. [Abstract] [Full Text] [PDF]